BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10407217)

  • 1. Effect of TRH on beta-gonadotropin subunits in patients with pituitary microincidentalomas.
    Greenman Y; Trostanetsky Y; Sömjen D; Tordjman K; Kohen F; Stern N
    Eur J Endocrinol; 1999 Jul; 141(1):17-21. PubMed ID: 10407217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal response of luteinizing hormone beta subunit to thyrotrophin-releasing hormone in patients with non-functioning pituitary adenoma.
    Gil-del-Alamo P; Pettersson KS; Saccomanno K; Spada A; Faglia G; Beck-Peccoz P
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):661-6. PubMed ID: 7828356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of thyrotropin-releasing hormone on gonadotropin and free alpha-subunit secretion in patients with acromegaly and functionless pituitary tumors.
    Popovic V; Damjanovic S
    Thyroid; 1998 Oct; 8(10):935-9. PubMed ID: 9827662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined beta FSH and beta LH response to TRH in patients with clinically non-functioning pituitary adenomas.
    Somjen D; Tordjman K; Kohen F; Baz M; Razon N; Ouaknine G; Stern N
    Clin Endocrinol (Oxf); 1997 May; 46(5):555-62. PubMed ID: 9231051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of beta-subunits of gonadotrophin hormones in the follow-up of clinically non-functioning pituitary tumours.
    Greenman Y; Tordjman K; Sömjen D; Reider-Groswasser I; Kohen F; Ouaknine G; Stern N
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):185-90. PubMed ID: 9828905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRH is a tonic secretagogue in growth hormone secreting but not in nonfunctioning pituitary tumors.
    Somjen D; Tordjman K; Greenman Y; Kohen F; Ouaknine GE; Stern N
    J Endocrinol Invest; 1999 Feb; 22(2):104-8. PubMed ID: 10195376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine.
    Kwekkeboom DJ; de Jong FH; Lamberts SW
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1128-35. PubMed ID: 2542356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired estrogen-induced negative feedback on gonadotropin secretion in patients with gonadotropin-secreting and nonfunctioning pituitary adenomas.
    Lania A; Gangi E; Romoli R; Losa M; Travaglini P; Meringolo D; Ambrosi B; Faglia G; Beck-Peccoz P; Spada A
    Eur J Clin Invest; 2002 May; 32(5):335-40. PubMed ID: 12027873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free luteinizing-hormone beta-subunit in normal subjects and patients with pituitary adenomas.
    Chanson P; Pantel J; Young J; Couzinet B; Bidart JM; Schaison G
    J Clin Endocrinol Metab; 1997 May; 82(5):1397-402. PubMed ID: 9141523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
    Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
    J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood serum concentrations of gonadotropins and α-subunit in patients with gonadotropinomas in relation to the immunoreactivity of pituitary adenoma.
    Pawlikowski Łódź M; Jaranowska M; Fryczak J; Radek M; Świętosławski J; Kunert-Radek J; Winczyk K
    Endokrynol Pol; 2018; 69(5):526-529. PubMed ID: 30074232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of possible paradoxical responses of gonadotropins to thyrotropin-releasing hormone with bromocriptine therapy in a patient with follicle-stimulating hormone-secreting pituitary adenoma.
    Mercado-Asis LB; Yasuda K; Ishizawa M; Ishizuka T; Murayama M; Shimokawa K; Miura K
    Endocrinol Jpn; 1992 Aug; 39(4):401-6. PubMed ID: 1446655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of thyrotropin-releasing hormone test, SMS 201-995, and bromocriptine in the diagnosis and treatment of gonadotropin-secreting pituitary adenomas.
    Blanco C; Lucas T; Alcañiz J; Davila N; Serrano P; Barcelò B; Estrada J
    J Endocrinol Invest; 1994 Feb; 17(2):99-104. PubMed ID: 8006339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary secretion of free alpha and beta subunit of human thyrotropin in patients with thyroid disorders.
    Kourides IA; Weintraub BD; Ridgway EC; Maloof F
    J Clin Endocrinol Metab; 1975 May; 40(5):872-85. PubMed ID: 1127093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypophyseal gonadotropins after GnRH in patients with pituitary tumors].
    Morosini PP; Carletti P; Campanella N; Ferretti GF
    Boll Soc Ital Biol Sper; 1980 Jun; 56(12):1243-7. PubMed ID: 6779829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of gonadotroph adenomas in men with clinically nonfunctioning adenomas by the luteinizing hormone beta subunit response to thyrotropin-releasing hormone.
    Daneshdoost L; Gennarelli TA; Bashey HM; Savino PJ; Sergott RC; Bosley TM; Snyder PJ
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1352-5. PubMed ID: 8077332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of gonadotroph adenomas in women.
    Daneshdoost L; Gennarelli TA; Bashey HM; Savino PJ; Sergott RC; Bosley TM; Snyder PJ
    N Engl J Med; 1991 Feb; 324(9):589-94. PubMed ID: 1899470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
    Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT
    J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function.
    Scott JZ; Kletzky OA; Brenner PF; Mishell DR
    Fertil Steril; 1978 Aug; 30(2):141-5. PubMed ID: 98356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo secretory potential and the effect of combination therapy with octreotide and cabergoline in patients with clinically non-functioning pituitary adenomas.
    Andersen M; Bjerre P; Schrøder HD; Edal A; Høilund-Carlsen PF; Pedersen PH; Hagen C
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):23-30. PubMed ID: 11167922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.